10155 Results for "

in

" in MedChemExpress (MCE) Product Catalog:
Products (10155)

10155 Results for "in" in MCE Product Catalog:

59
59 Publications Verification
Cat. No.: HY-13319
CAS No.: 1410880-22-6
Purity:  99.67%
Synonyms: JNK inhibitor XVI
Target:  

JNK

Research Areas:  

Cancer

JNK-IN-8 (JNK Inhibitor XVI) is a potent JNK inhibitor with IC50s of 4.7 nM, 18.7 nM, and 1 nM for JNK1, JNK2, and JNK3, respectively .
loading...
    loading...
33
33 Cited Publications
Cat. No.: HY-138489
CAS No.: 1424635-83-5
Purity:  99.22%
Synonyms: Lats-in-1
Research Areas:  

Others

TRULI (Lats-IN-1) is a potent and ATP-competitive inhibitor of Lats1 and Lats2 kinases. TRULI promotes Yap-dependent proliferation in postmitotic mammalian tissues .
loading...
    loading...
32
32 Cited Publications
Cat. No.: HY-101853
CAS No.: 285986-31-4
Purity:  98.35%
Target:  

STAT

Research Areas:  

Cancer

STAT5-IN-1 is a STAT5 inhibitor with an IC50 of 47 μM for STAT5β isoform.
loading...
    loading...
27
27 Cited Publications
Cat. No.: HY-100877
CAS No.: 1448693-69-3
Purity:  ≥98.0%
Research Areas:  

Cancer

GCN2-IN-1 is a potent general control nonderepressible 2 kinase (GCN2) inhibitor with an IC50 of <0.3 μM in the enzyme assay and an IC50 of 0.3-3 μM in the cell assay .
loading...
    loading...
27
27 Cited Publications
Cat. No.: HY-103617
CAS No.: 94164-88-2
Purity:  99.79%
Target:  

Pyruvate Kinase

Research Areas:  

Cancer

PKM2-IN-1 (compound 3k) is a pyruvate kinase M2 (PKM2) inhibitor with an IC50 of 2.95 μM .
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-12836
CAS No.: 844882-93-5
Target:  

IFNAR

Research Areas:  

Inflammation/Immunology

IFN alpha-IFNAR-IN-1 is a nonpeptidic, low-molecular-weight inhibitor of the interaction between IFN-α and IFNAR. IFN alpha-IFNAR-IN-1 inhibits modified Vaccinia virus ankara (MVA)-induced IFN-α responses in murine bone-marrow-derived, Flt3- L-differentiated pDC cultures (BM-pDCs) (IC50=2-8 μM) .
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-12836A
CAS No.: 2070014-98-9
Purity:  99.76%
Target:  

IFNAR

Research Areas:  

Inflammation/Immunology

IFN alpha-IFNAR-IN-1 hydrochloride is a nonpeptidic, low-molecular-weight inhibitor of the interaction between IFN-α and IFNAR. IFN alpha-IFNAR-IN-1 hydrochloride inhibits modified Vaccinia virus ankara (MVA)-induced IFN-α responses in murine bone-marrow-derived, Flt3- L-differentiated pDC cultures (BM-pDCs) (IC50=2-8 μM) .
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-129047E
CAS No.: 9002-07-7
Target:  

Ser/Thr Protease

Research Areas:  

Others

Trypsin, porcine pancreas (Cell culture grade) is a serine protease that hydrolyzes proteins at the carboxyl side of lysine or arginine residues. Trypsin, porcine pancreas (Cell culture grade) exhibits excellent protein digestibility for α-lactalbumin and β-casein. Trypsin, porcine pancreas (Cell culture grade) removes cellular components while preserving extracellular matrix structures to achieve uniform decellularization of porcine pancreas .
loading...
    loading...
23
23 Cited Publications
Cat. No.: HY-B0322B
CAS No.: 723-46-6
Synonyms: Ro 4-2130 1000 µg/mL in methanol
Target:  

Antibiotic Bacterial

Research Areas:  

Infection

Sulfamethoxazole (Ro 4-2130) 1000 μg/mL in methanol is a sulfonamide antibiotic with a widespread antibacterial activity. Sulfamethoxazole 1000 μg/mL in methanol inhibits bacterial folate metabolism by competing with 4-Aminobenzoic acid (HY-B1008) (PABA) to act on dihydropteroate synthetase and dihydropteroate reductase. Sulfamethoxazole 1000 μg/mL in methanol can be used for the study of urinary tract infections (UTIs), prostatitis, and bronchitis .
loading...
    loading...
21
21 Cited Publications
Cat. No.: HY-50737A
CAS No.: 924296-19-5
Target:  

Deubiquitinase

Research Areas:  

Cancer

DUB-IN-2 is a potent deubiquitinase inhibitor with an IC50 of 0.28 μM for USP8 .
loading...
    loading...
20
20 Cited Publications
Cat. No.: HY-100004
CAS No.: 1644060-37-6
Purity:  99.14%
Research Areas:  

Cancer

Fumarate hydratase-IN-1 (compound 2) is a cell-permeable fumarate hydratase inhibitor. Fumarate hydratase-IN-1 has antiproliferative activity against several cancer cell lines with a mean IC50 of 2.2 μM .
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-14176
CAS No.: 209986-17-4
Purity:  99.97%
Synonyms: γ-Secretase-in-1
Target:  

γ-secretase

Research Areas:  

Cancer

Compound E is a γ-secretase inhibitor. Compound E blocks β-amyloid(40), β-amyloid(42), and Notch γ-secretase cleavage with IC50s of 0.24, 0.37, 0.32 nM, respectively.
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-12795
CAS No.: 1383716-33-3
Purity:  99.79%
Target:  

PI3K Autophagy

Research Areas:  

Cancer

Vps34-IN-1 is a potent and selective inhibitor of class III Vps34 PI3K. Vps34-IN-1 inhibits phosphorylation of PtdIns by recombinant insect cell expressed Vps34-Vps15 complex with an IC50 of ~25 nM. Vps34-IN-1 can suppress SGK3 activation by reducing PtdIns(3)P levels via lowering phosphorylation of T-loop and hydrophobic motifs. Vps34-IN-1 modulates autophagy .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-148439
CAS No.: 2765081-21-6
Purity:  99.68%
Synonyms: RMC-6236; RAS-in-2
Target:  

Ras PERK

Research Areas:  

Cancer

Daraxonrasib (RMC-6236) is an orally active, non-covalent RAS (ON) inhibitor. Daraxonrasib disrupts the interaction of wild-type or mutant RAS proteins with the RAS binding domain of BRAF, with EC50 values ranging from 28-220 nM for wild-type KRAS, NRAS, HRAS, and multiple oncogenic RAS variants. Daraxonrasib inhibits pERK. Daraxonrasib has anti-tumor activity against KRAS mutant tumors .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-13452
CAS No.: 314042-01-8
Purity:  99.71%
Synonyms: ML282
Target:  

Ras

Research Areas:  

Inflammation/Immunology

CID-1067700 (ML282) is a pan GTPase inhibitor, and competitively inhibits Ras-related in brain 7 (Rab7) with a Ki of 13 nM.
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-N0378
CAS No.: 69-65-8
Synonyms: Mannitol; Mannite
D-Mannitol (Mannitol) is an oral, resistant sugar widely used in the food and pharmaceutical industries to promote the absorption and retention of calcium and magnesium through cecal fermentation, while acting as a osmotic diuretic to reduce tissue edema. D-Mannitol can enhance brown fat formation, improve insulin effect, reduce blood sugar levels, And through the start the β3-adrenergic receptor (β3-AR), PGC1α and PKA induced by means of white fat cells into brown fat cells . D-Mannitol is commonly used to maintain osmotic pressure between the plant cytoplasm and the culture medium and protect cells when the cell wall is weakened or even removed .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-Y0966
CAS No.: 56-40-6
Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors. Glycine is orally active. Glycine inhibits the membrane aggregation of NINJ1 and prevents plasma membrane rupture during cell death. Glycine can be used to study cell protection, cancer, neurological diseases, and angiogenesis .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-107575
CAS No.: 40592-88-9
Purity:  99.90%
Research Areas:  

Inflammation/Immunology

TLR4-IN-C34 is an orally active TLR4 inhibitor and reduces systemic inflammation in models of endotoxemia and necrotizing enterocolitis .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-12839
CAS No.: 1006378-90-0
Purity:  99.58%
Target:  

p38 MAPK Autophagy

Research Areas:  

Inflammation/Immunology

p38 MAPK-IN-1 (Compound 4) is a novel potent and selective inhibitor of p38 MAPK with IC50 of 68 nM. p38 MAPK-IN-1 shows sustained levels, low clearance and good bioavailability.
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-100198
CAS No.: 1881233-39-1
Purity:  99.84%
Target:  

PI4K PI3K

Research Areas:  

Infection

PI4KIIIbeta-IN-10 is a potent PI4KIIIβ inhibitor with an IC50 of 3.6 nM.
loading...
    loading...